Per MD - Strongbridge Biopharma Insider

Strongbridge Biopharma plc -- USA Stock  

USD 6.25  0.05  0.81%

Founder and Sr. Clinical Advisor

We currently do not have informatin regarding Per MD. This executive tanure with Strongbridge Biopharma plc is not currenlty determined.
        
610-254-9200  http://www.strongbridgebio.com

Management Efficiency

The company has return on total asset (ROA) of (29.66) % which means that it has lost $29.66 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (213.37) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 18.57 M in liabilities with Debt to Equity (D/E) ratio of 188.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Strongbridge Biopharma plc has Current Ratio of 4.54 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

Strongbridge Biopharma plc, a biopharmaceutical company, focuses on the development, inlicensing, acquisition, and commercialization of various complementary solutions and product candidates that target rare diseases. Strongbridge Biopharma plc (SBBP) is traded on NASDAQ in USA. It is located in PENNSYLVANIA, U.S.A and employs 10 people. Strongbridge Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Portfolio Quick Import Now
   

Portfolio Quick Import

Import or update all your transactions via one easy-to-use interface
Hide  View All  Next  Launch Portfolio Quick Import
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Strongbridge Biopharma plc to your portfolio

Top Management

Strongbridge Biopharma Leadership Team
Matthew Pauls, CEO, MBA
Brian Davis, CFO, MBA
Richard Kollender, Director
Davis, CFO, MBA
Robert Lutz, Executive, MBA
Garheng Kong, Director, MBA
John Johnson, Chairman
Marten Steen, Director, Ph.D
Stephen Long, Executive
Ruth MD, Executive
Ruth ThieroffEkerdt, Executive, Ph.D
Hilde Steineger, Director, Ph.D
Per MD, Founder

Stock Performance

Strongbridge Biopharma Performance Indicators